These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7013321)

  • 1. [Kidneys as an effector in the regulation of blood clotting].
    Sokratov NV; Skipetrov VP
    Usp Fiziol Nauk; 1981; 12(1):80-96. PubMed ID: 7013321
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of specific adreno- and choline-receptors in the vascular wall in the regulation of blood coagulation during stimulation of the vagus nerve].
    Mishchenko VP
    Biull Eksp Biol Med; 1974 Aug; 78(8):19-22. PubMed ID: 4433751
    [No Abstract]   [Full Text] [Related]  

  • 3. [The gastrointestinal tract as a local regulator and organ-effector of the blood coagulation system].
    Golyshenkov SP
    Usp Fiziol Nauk; 1986; 17(3):80-91. PubMed ID: 3529681
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood coagulation system and fibrinolysis in glomerulonephritis (review of the literature)].
    Panchenko VM; Gilunova NI; Kozhomkulova BZh
    Lab Delo; 1977; (8):451-4. PubMed ID: 72846
    [No Abstract]   [Full Text] [Related]  

  • 5. [Universal mechanism for regulating blood clotting and fibrinolysis].
    Kuznik BI
    Usp Sovrem Biol; 1979; 87(1):108-24. PubMed ID: 373283
    [No Abstract]   [Full Text] [Related]  

  • 6. [Importance of the kidneys in regulating blood coagulation and fibrinolysis].
    Sokratov NV; Skipetrov VP; Safronova TA
    Urol Nefrol (Mosk); 1977; (4):80-5. PubMed ID: 898434
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of cholino- and adrenoreactive formations in the regulation of kidney excretion of blood-coagulating compounds].
    Sokratov NV; Skipetrov VP
    Fiziol Zh SSSR Im I M Sechenova; 1977 Dec; 63(12):1728-32. PubMed ID: 598547
    [No Abstract]   [Full Text] [Related]  

  • 8. [The stimulation of fibrinolysis during cholinergic vasodilating reactions].
    Bashkov GV; Sergeev IIu; Medvedeva NA; Makarov VA
    Fiziol Zh (1978); 1990; 36(4):3-8. PubMed ID: 2146171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary fibrinolytis activity and the blood coagulation system in chronic pyelonephritis].
    Khvan PT
    Urol Nefrol (Mosk); 1980; (1):10-3. PubMed ID: 7368430
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.
    Nishida Y; Hayashi Y; Imai Y; Itoh H
    Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental and clinical studies on coagulation and fibrinolysis in toxemia of pregnancy].
    Motohara N
    Nihon Jinzo Gakkai Shi; 1983 Feb; 25(2):215-26. PubMed ID: 6620689
    [No Abstract]   [Full Text] [Related]  

  • 12. Salmeterol enhances pulmonary fibrinolysis in healthy volunteers.
    Maris NA; de Vos AF; Bresser P; van der Zee JS; Jansen HM; Levi M; van der Poll T
    Crit Care Med; 2007 Jan; 35(1):57-63. PubMed ID: 17080003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on cortical tissue plasminogen activator in renal disease. Part I: Studies in the glomerulonephritis (author's transl)].
    Morozumi K
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):153-66. PubMed ID: 7201539
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
    Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD
    Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of kidney elimination on fibrinolysis and clotting factors in dog blood plasma.
    Worowski K; Poplawski A; Kochańska J; Niewiarowski S
    Bull Acad Pol Sci Biol; 1965; 13(11):683-5. PubMed ID: 5886176
    [No Abstract]   [Full Text] [Related]  

  • 16. Physiological consequences of loss of plasminogen activator gene function in mice.
    Carmeliet P; Schoonjans L; Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC
    Nature; 1994 Mar; 368(6470):419-24. PubMed ID: 8133887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
    Wilson MJ; Ludowese C; Sinha AA; Estensen RD
    Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
    Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
    Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of coagulation and fibrinolysis parameters in animals.
    Karges HE; Funk KA; Ronneberger H
    Arzneimittelforschung; 1994 Jun; 44(6):793-7. PubMed ID: 8053983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical staining of urokinase plasminogen activator-like and urokinase plasminogen activator receptor-like proteins in the urinary tract of healthy dogs.
    Bailey TR; Paulsen DB; Sehgal I; Hosgood G
    Am J Vet Res; 2006 Sep; 67(9):1628-34. PubMed ID: 16948613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.